Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04738838
Other study ID # IRB-2020-0002
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date May 20, 2022
Est. completion date July 29, 2022

Study information

Verified date February 2024
Source Florida Institute for Human and Machine Cognition
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Naval Special Warfare (NSW) operators are exposed to a variety of extreme environmental conditions and intense physical demands. In addition to breathing high pressure gases at depth, prolonged cold water immersion and inadequate recovery from sustained physical exertion negatively impact individual and team performance. Biotechnologies that could mitigate the effects of cold as well as support physical recovery represent a significant unmet need for the NSW operational community. Oxytocin (OT) has a wide range of actions both locally in the brain and peripherally in the body including skeletal muscle. These peripheral effects can be mediated by classic ligand-receptor activation given the abundant expression of the oxytocin receptor in peripheral tissues, along with local expression of OT in peripheral tissues where it is likely to act in an autocrine manner. Exogenous OT via intranasal administration is FDA Investigational New Drug (IND)-approved and has been demonstrated as an easy and safe method to increase circulating OT concentrations that may augment actions on peripheral tissues.


Description:

Naval Special Warfare (NSW) operators are exposed to a variety of extreme environmental conditions and intense physical demands. In addition to breathing high pressure gases at depth, prolonged cold water immersion and inadequate recovery from sustained physical exertion negatively impact individual and team performance. Biotechnologies that could mitigate the effects of cold as well as support physical recovery represent a significant unmet need for the NSW operational community. Oxytocin (OT) has a wide range of actions both locally in the brain and peripherally in the body including skeletal muscle. These peripheral effects can be mediated by classic ligand-receptor activation given the abundant expression of the oxytocin receptor in peripheral tissues, along with local expression of OT in peripheral tissues where it is likely to act in an autocrine manner. Exogenous OT via intranasal administration is FDA Investigational New Drug (IND)-approved and has been demonstrated as an easy and safe method to increase circulating OT concentrations that may augment actions on peripheral tissues. Cold water operators undergo an extensive and unique set of physical, physiological, and psychological stressors during a mission. In-water transit may exceed 6 hours submerged in cold water, on rebreathers, and in a confined space. During this lengthy transit, operators must maintain vigilance over navigation, vehicle, and life support controls while exposed to the risks of mixed gas or oxygen rebreather diving, alongside hypothermia, dehydration, undernutrition, and other factors that can significantly degrade operator performance. Once the team has reached target, they must be at peak cognitive and physical readiness as they carry out their mission objective. When the mission objective is complete, the operators undertake the lengthy return trip back to their deployed base. Optimized operator cognitive and physical performance is essential throughout all phases of a cold water mission, and safe and tolerable approach to optimizing warfighter performance and resilience will be key for future cold water operations. Given the potential thermogenic and recovery effects or intranasal OT, we hypothesize that prophylactic OT administration, compared to placebo, will mitigate deficits in mission-relevant performance during and after cold water exposure. For this project we will utilize the ONR Cold Water Performance Task Battery, which was designed based on results from a task analysis combined with input from the cold water operator community. The task battery has been validated for its ability to induce changes in core and peripheral body temperature, manual dexterity, cognitive performance, and physical performance following cold water exposure. Our hypothesis will be tested via one specific aim enrolling N=24 18-39 y/o men by using a rigorous, double-blind, placebo- controlled, within-subjects randomized cross-over trial comparing 48 IU OT vs placebo (saline) in cold water performance and recovery. Specific Aim 1. To investigate the impact of intranasal OT on cold water task performance and recovery using the ONR Cold Water Performance Task Battery, which includes cold water exposure; cognitive performance testing via oculometric assessment and the Defense Automated Neurobehavioral Assessment (DANA); and physical performance testing via a simulated ruck, ladder climb, and manual dexterity testing.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date July 29, 2022
Est. primary completion date July 29, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - Recreationally skilled swimmers Exclusion Criteria: - Smoking/vaping, a history of psychiatric disorders, safety requirements related to the oxytocin administration [hypersensitivity to oxytocin or vasopressin, history of hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, or psychogenic polydipsia, on vasoconstrictors such as desmopressin, pseudoephedrine, or antidiuretic medication, or anti-inflammatory drugs, or muscle relaxants, low sodium and high osmolality levels, excessive smoking, excessive drinking, and significant nasal pathology.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Oxytocin nasal spray
Intranasal treatment with oxytocin via nasal spray (48 IU per dose)
Placebo nasal spray
Intranasal treatment with placebo via nasal spray

Locations

Country Name City State
United States University of Florida Gainesville Florida
United States Florida Institute for Human and Machine Cognition Pensacola Florida

Sponsors (3)

Lead Sponsor Collaborator
Florida Institute for Human and Machine Cognition Office of Naval Research (ONR), University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Difference in grip strength in cold water During and after cold water exposure, participants will complete a grip strength assessment through the use of a hand dynamometer. Measurements will be taken in Newtons. Within 3 hours post-treatment
Other Difference in manual dexterity (underwater knot untying) in cold water During and after cold water exposure, participants will complete a timed underwater knot untying and peg board time trial. Measurement will be recorded in seconds. Within 3 hours post-treatment
Other Difference in manual dexterity (underwater peg board assessment) in cold water During and after cold water exposure, participants will complete a timed underwater peg board assessment time trial. Measurement will be recorded in seconds. Within 3 hours post-treatment
Primary Cognitive performance assessment score change (code substitution) Changes in code substitution scores as measured by the Defense Automated Neurobehavioral Assessment (DANA). Data will be measured in milliseconds for response time. Within 3 hours post-treatment
Primary Cognitive performance assessment score change (code substitution) Changes in code substitution scores as measured by the Defense Automated Neurobehavioral Assessment (DANA). Data will be measured in number of correct or incorrect responses. Within 3 hours post-treatment
Primary Cognitive performance assessment score change (reaction time) Changes in choice reaction time scores as measured by the Defense Automated Neurobehavioral Assessment (DANA). Data will be measured in milliseconds for response time. Within 3 hours post-treatment
Primary Cognitive performance assessment score change (reaction time) Changes in choice reaction time scores as measured by the Defense Automated Neurobehavioral Assessment (DANA). Data will be measured in number of correct or incorrect responses. Within 3 hours post-treatment
Primary Oculometric assessment score change (saccades) Altered ocular response as measured by the I-Portal Portable Assessment System (i-PAS). Saccades will be monitored and counted throughout the duration of the assessment. Within 3 hours post-treatment
Primary Oculometric assessment score change (blink rate) Altered ocular response as measured by the I-Portal Portable Assessment System (i-PAS). Number of blinks will be counted through the course of the assessment. Within 3 hours post-treatment
Primary Oculometric assessment score change (blink duration) Altered ocular response in blink duration as measured by the I-Portal Portable Assessment System (i-PAS). Blink duration will be measured in milliseconds. Within 3 hours post-treatment
Secondary Reduced rating of perceived exertion (RPE) during physical assessment post-cold water exposure Participants will signal on the Borg (6-20) scale for whole body and lower body exertion following their exposure to cold water. Lower on the scale signal a lower level of perceived physical exertion. Within 3 hours post-treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03541096 - Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT). N/A
Recruiting NCT05584527 - Assessment of the Effects of a 24-hour Cold and Heat Exposure on the Factors Influencing Food Intake
Not yet recruiting NCT06424132 - Thermogenic Silencer Regulatory Factors in Humans N/A
Completed NCT05107570 - The Effect of Cold Exposure on Energy Expenditure N/A
Completed NCT05894031 - The Effectiveness of the Wim Hof Method N/A
Recruiting NCT05822141 - Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure N/A
Completed NCT01483885 - Comparison of the Analgesic Effects of Acupuncture and Modulated Electroanalgesia in Cold Induced Pain Phase 1/Phase 2
Recruiting NCT04359082 - Cocoa-rich Bioflavanol Supplementation Effects During Cold Exposure N/A
Recruiting NCT06159374 - Effects of Physical Training in Altered Environmental Conditions on Exercise Performance N/A
Active, not recruiting NCT06223087 - Effects of Winter Swimming on Blood Indicators and Oxidative Stress in Males
Completed NCT05545943 - Effects of Calorie Restriction and Cold Stimuli on Health-related Indicators, Cognitive and Motor Functions N/A
Recruiting NCT05076357 - Cold, Appetite and Weight Loss in Individuals With Obesity N/A
Recruiting NCT05464758 - The Effects of Cold Adaptation on Skin Blood Flow, Hand Function, and Comfort in Healthy Adults N/A
Completed NCT03240497 - Effects of Cold Exposure and Breathing Techniques on Immune Response N/A